LETRO-DENK 2.5 Price

Overview

Welcome to Dwaey, specifically on LETRO-DENK 2.5 Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Letrozole.
LETRO-DENK 2.5 is available in the market in concentration 2.5mg/Tablet and in the form of Tablets/Film-coated.

DENK PHARMA GmbH & Co. KG is the producer of LETRO-DENK 2.5 and it is imported from GERMANY, The most popular alternatives of LETRO-DENK 2.5 are listed downward .

Mode Of Action

Letrozole competitively binds to the heme group of aromatase, a cytochrome P450 enzyme which catalyzes conversion of androgen to oestrogen, leading to inhibition of the enzyme and a significant reduction in plasma oestrogen levels.

Indication

• Breast cancer

Precaution

Severe renal impairment; severe hepatic impairment; osteoporosis. Caution when driving or operating machinery. Lactation: not known if excreted in breast milk (for post-menopausal women)

Side Effects

• Hot flushes
• arthralgia
• nausea
• vomiting
• fatigue
• dizziness
• headache
• dyspepsia
• constipation
• diarrhoea
• anorexia
• alopoecia
• increased sweating
• rash
• peripheral oedema
• osteoporosis
• musculoskeletal pain
• vaginal irritation. Potentially Fatal: Thromboembolic events.

Contra indication

Premenopausal women and children; hypersensitivity.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.